We are thrilled to announce a significant stride in Clinical Accelerator’s journey as we extend our business operations to Uzbekistan. This expansion marks a pivotal moment in our mission to advance clinical research and clinical trial solutions globally.

A Glimpse into Uzbekistan’s Healthcare Landscape:

With its rich history and diverse culture, Uzbekistan presents unique opportunities in the realm of clinical research with novel medical technologies. It boasts the best of both worlds, having Western-like healthcare but remaining outside of the European Union and therefore outside the scope of the EU Medical Device Regulations. Excellent access to patients will ensure fast and efficient enrolment in our clinical trials in this location. This strategic positioning opens doors to more streamlined regulatory pathways for early-stage clinical trials with novel medical devices and accelerates execution of all types of clinical studies in cardiovascular and other important therapeutic areas.

In conjunction with Clinical Accelerator’s experienced study start-up team who will work with Sponsors on putting together the CTA[1], the contract negotiation process with hospitals, acquiring local insurance, and importation logistics, setting up study files and preparing sites for the study launch, the start-up timeline that Sponsors should expect to initiate a clinical trial is approximately 8 weeks. Clinical Accelerator offers full support for management and monitoring of clinical studies in these locations together with our centralized services for medical monitoring and safety management, electronic data capture, data management, statistical analyses and medical writing.

In our commitment to excellence, we are proud to announce partnerships with a group of leading institutions in various therapetuics areas. Clinical Accelerator will be strengthening clinical research capabilities of these institutions by embedding our own clinical research co-ordinators into the sites’ structure. The sites are open to collaborating with visiting experts and strengthening ties with leading academic sites in the United States, Europe, Israel and Asia. These collaborations will amplify our ability to conduct robust clinical trials and research, propelling projects of our clients and partners towards faster commercialization of their novel medical technologies and eventually meeting unmet medical needs and improving patient care for all.

Embracing a New Chapter:

We embark on this expansion with boundless enthusiasm. Clinical Accelerator’s projects in Uzbekistan have successfully started this summer and are progressing at full speed and we are looking forward to their further evolution.

If you would like to explore these new options for your planned or on-going clinical studies, we invite you to reach out to our dedicated Business Development Representative, Anna Nikitina.

Contact Anna Nikitina:

Email: anna.nikitina@clinicalaccelerator.com

Thank you for your continued support as we take these bold steps forward.

Clinical Accelerator Team.

---

[1] Clinical Trial Application